 defect cytostat activ pulmonari alveolar macrophag primari lung cancer macrophag import immun effector cell role antitumor host defens unclear pam antitumor activ patient lung cancer normal impair pam cytostasi patient lung cancer control subject vitro pam respons gamma-interferon nineteen patient primari lung carcinoma control patient underw bal patient cancer underw lavag lung abnorm proxim part gener defect cytostat activ inhibit incorpor tritiat thymidin target cell signific differ baselin cytostat activ patient cancer mean SE percent control patient percent increas cytostat function stimul gamma-interferon units/ml group cancer percent increas baselin control percent cytostasi stimul differ group group baselin cytostat activ differ cancer noncancer lung control subject result pam cytostat activ patient cancer control gamma-interferon cytostat function patient cancer level compar achiev control patient pam abnorm part immun defect lung cancer local respons carcinoma result patient primari lung cancer vivo defect cell lymphokin product macrophag dysfunct